Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide,relatlimab
Genmab,Abbvie,BMS
['dlbcl', 'lymsm', 'epcoritamab']
congress| #asco23 presents longer term results of patients with dlbcl treated with epcoritamab+r-chop. the latest results support the preliminary data and this treatment induces high cmr rates with a manageable safety profile #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm